BOSENTIME 125 & Bosentan (125mg) : Uses, Side Effects, Interactions, Dosage and Call to action.

Apr 16, 2024

BOSENTIME 125

Bosentan (125mg),

BOSENTIME 125, is a medication containing Bosentan, prescribed primarily for the treatment of pulmonary arterial hypertension (PAH). This article offers an in-depth exploration of its uses, dosage, side effects, pricing, composition, and more, providing valuable insights for patients and healthcare professionals alike.

Uses:

Pulmonary Arterial Hypertension (PAH): BOSENTIME 125 is indicated for the management of PAH, a progressive condition characterized by elevated blood pressure in the arteries supplying the lungs. Bosentan, the active ingredient in BOSENTIME 125, exerts its therapeutic effects by antagonizing endothelin receptors, leading to vasodilation of pulmonary blood vessels and reduction of pulmonary vascular resistance. This results in improved exercise capacity and delayed disease progression in patients with PAH.
Dosage:
The dosage of BOSENTIME 125 is individualized based on various factors such as the patient's age, weight, and severity of PAH. It is typically administered orally, with or without food, as directed by a healthcare provider. Close monitoring of liver function is essential during treatment with Bosentan due to the risk of hepatotoxicity. Dosage adjustments may be necessary, and patients should not alter their dosage without consulting their healthcare provider.

Side Effects:
While BOSENTIME 125 is effective in managing PAH, it may cause certain adverse effects. Common side effects may include headache, flushing, peripheral edema, nasal congestion, and gastrointestinal disturbances. Additionally, Bosentan has been associated with hepatotoxicity, necessitating regular monitoring of liver function tests. Patients should promptly report any new or worsening symptoms to their healthcare provider.

Price:
The pricing of BOSENTIME 125 can vary depending on factors such as brand, formulation, and geographic location. It may be available in both branded and generic versions, with generic alternatives often offering cost-effective options. Patients are advised to inquire about pricing and potential insurance coverage from their healthcare provider or pharmacist.

Composition:
Each BOSENTIME 125 tablet contains Bosentan as the active pharmaceutical ingredient, with a dosage strength of 125 mg. The formulation also includes inactive ingredients necessary for tablet manufacturing. Patients should inform their healthcare provider of any known allergies or sensitivities to Bosentan or other components of the formulation before initiating therapy.

Conclusion:
In summary, BOSENTIME 125, containing Bosentan, is a valuable therapeutic option for the management of PAH. By targeting endothelin receptors and reducing pulmonary vascular resistance, Bosentan improves symptoms and quality of life for patients with PAH. However, vigilant monitoring for adverse effects, particularly hepatotoxicity, is essential during treatment. Patients should adhere to prescribed dosages and promptly report any concerns to their healthcare provider to ensure safe and effective therapy. A team of highly skilled professionals in the pharmaceutical field established Steris Healthcare Pvt Ltd in February 2018. Sterispharma is a certified pharmaceutical company by WHO, GMP, and ISO, situated in Navi Mumbai. It is dedicated to delivering high-quality medications at competitive prices to customers across India, adhering to WHO's stringent standards. Through Steris's online pharmacy, customers can conveniently purchase medicines and receive home delivery. Our primary objective at Steris is to offer a comprehensive range of healthcare products to fulfill the diverse requirements of the healthcare industry. Steris is committed to meeting the healthcare sector's demands, whether it's specialized treatments, medications for rare diseases, or essential pharmaceuticals. The range of Steris healthcare products caters to various medical needs, including Cardiology, Asthma, Respiratory, Nasal, Diabetes, Endocrinology, Gastrology, Orthopedics, Anti-infective/antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental, and Dermatology.  For further information:  EMAIL:  info@sterispharma.com  / contact@sterispharma.com     CALL/WHATSAPP:: 7877551268, 8209542042, 8955945010, 6377716668  BUY NOW

SHARE WITH